Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alto Neuroscience Inc ANRO

Healthcare
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. Through insights derived from the Company’s scalable and proprietary Precision Psychiatry Platform, which applies rigorous data science and robust analytics to data gathered by... see more

Recent & Breaking News (NYSE:ANRO)

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 8 hours ago

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire 1 day ago

The Schall Law Firm Invites Shareholder Contributions To An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 2 days ago

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Encouraged To Reach Out To The Schall Law Firm

Accesswire 4 days ago

The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 5 days ago

The Schall Law Firm Requests Stockholders To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 7 days ago

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Accesswire 8 days ago

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 9 days ago

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Accesswire 10 days ago

The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire 11 days ago

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire 12 days ago

The Schall Law Firm Wants Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Fraud

Accesswire 13 days ago

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire November 17, 2024

The Schall Law Firm Invites Stockholders To Join An Inquiry Into Alto Neuroscience, Inc.'s Possible Fraud

Accesswire November 16, 2024

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Accesswire November 15, 2024

The Schall Law Firm Invites Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire November 14, 2024

Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Accesswire November 13, 2024

Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Business Wire November 12, 2024

The Schall Law Firm Invites Stockholders To Take Part In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire November 12, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Accesswire November 11, 2024